Evenemang

På den här sidan finner du senaste nyheter och evenemang där Medac kommer att delta.

  1. EAU19 (European Association of Urology)

    15 mars, 2019 - 19 mars, 2019

  2. Nordic Congress of Dermatology & Venereology 2019

    8 maj, 2019 - 11 maj, 2019

  3. NUF Congress 2019 (Nordisk Urologisk Förening)

    5 juni, 2019 - 8 juni, 2019

  4. EULAR 2019 (European league against rheumatism)

    12 juni, 2019 - 15 juni, 2019

  5. Urologidagarna

    2 oktober, 2019 - 4 oktober, 2019

Nyheter

Press release – New conditioning therapy by medac about to receive European approval

Positive opinion from the CHMP for TRECONDI®  (treosulfan) by medac for toxicity-reducing conditioning for allogeneic haematopoietic stem cell transplantation. Further information can be found by clicking here

Medac has received the Yellow Hand Award

Medac received the Yellow Hand Award for the second consecutive time during the European Conference Oncology Pharmacy. The Yellow Hand Award is given by ESOP, European Society of Oncology Pharmacy. The Yellow Hand Award is awarded to companies who ensure safe transportation and handling of cystostatics throughout the complete supply chain and was first given in […]

Information om förpackningar av Metoject® (metotrexat)

Till följd av att allt fler användare av parenteralt metotrexat föredrar att använda Metojectpen® (förfylld injektionspenna) istället för Metoject® (förfylld spruta), anpassar Medac sig nu genom att minska ner antalet förpackningar av sprutorna, framför allt av de doser som börjar bli små i volym. De förpackningar/doser som nu successivt tas ur sortimentet är; Fortsatt kommer […]

Press release – Medac at the EADV Congress

Real-life data demonstrate the potential of methotrexate in severe and moderately severe psoriasis First French guidelines for psoriasis therapy – subcutaneous MTX is First-Line Paris / Wedel (14 September 2018). Methotrexate (MTX) is established and proven as an effective systemic first-line therapeutic agent in the treatment of psoriasis.1  MTX is and remains the world’s most […]

Press release – First marketing authorisation worldwide for methotrexate in moderate psoriasis

Medac’s marketing authorisation extension gives many patients with psoriasis access to guidelines-based MTX therapy for the first time. Click here to view full Press release

Medac ansvarar inte för innehållet på andra webbplatser!